1. Home
  2. VSH vs IOVA Comparison

VSH vs IOVA Comparison

Compare VSH & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • IOVA
  • Stock Information
  • Founded
  • VSH 1962
  • IOVA 2007
  • Country
  • VSH United States
  • IOVA United States
  • Employees
  • VSH N/A
  • IOVA N/A
  • Industry
  • VSH Electrical Products
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VSH Technology
  • IOVA Health Care
  • Exchange
  • VSH Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • VSH 2.2B
  • IOVA 2.6B
  • IPO Year
  • VSH N/A
  • IOVA N/A
  • Fundamental
  • Price
  • VSH $16.42
  • IOVA $6.07
  • Analyst Decision
  • VSH Buy
  • IOVA Strong Buy
  • Analyst Count
  • VSH 3
  • IOVA 9
  • Target Price
  • VSH $22.00
  • IOVA $23.33
  • AVG Volume (30 Days)
  • VSH 1.5M
  • IOVA 9.3M
  • Earning Date
  • VSH 02-05-2025
  • IOVA 02-26-2025
  • Dividend Yield
  • VSH 2.44%
  • IOVA N/A
  • EPS Growth
  • VSH N/A
  • IOVA N/A
  • EPS
  • VSH 0.62
  • IOVA N/A
  • Revenue
  • VSH $3,008,107,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • VSH N/A
  • IOVA $13,758.71
  • Revenue Next Year
  • VSH $4.40
  • IOVA $170.74
  • P/E Ratio
  • VSH $26.49
  • IOVA N/A
  • Revenue Growth
  • VSH N/A
  • IOVA 12751.20
  • 52 Week Low
  • VSH $14.95
  • IOVA $5.57
  • 52 Week High
  • VSH $24.69
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • VSH 43.10
  • IOVA 34.52
  • Support Level
  • VSH $16.04
  • IOVA $5.70
  • Resistance Level
  • VSH $17.63
  • IOVA $6.50
  • Average True Range (ATR)
  • VSH 0.55
  • IOVA 0.42
  • MACD
  • VSH -0.01
  • IOVA 0.07
  • Stochastic Oscillator
  • VSH 31.25
  • IOVA 28.25

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer worldwide. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: